Kamilla de Faria Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kamilla de Faria Santos has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Angela Adamski da Silva Reis
Universidade Federal de Goiás, Brasil; Universidade Federal de Goiás, Brasil
10 shared publications - Rodrigo da Silva Santos
Universidade Federal de Goiás, Brasil; Universidade Federal de Goiás, Brasil
10 shared publications - Leandro Do Prado Assunção
Universidade Federal de Goiás
5 shared publications - Dhiogo da Cruz Pereira Bento
Núcleo de Pesquisas em Neurogenética (NeuroGene), Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiania 74690-900, Goiás, Brazil
4 shared publications - Caroline Christine Pincela da Costa
Universidade Federal de Goiás, Brasil
3 shared publications - Rômulo Morais Azevedo
Federal University of Goiás, Goiânia. Institute of Biological Sciences (ICB). Department of Biochemistry and Molecular Biology. Laboratory of Molecular Pathology, (GO), Brazil
3 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 434
Genetic Variant-based Machine Learning Prediction of Diabetic Nephropathy: A Pilot Study in Brazilian Patients
Purpose: Diabetic nephropathy (DN) is a major microvascular complication of type 2 diabetes, where genetic predisposition significantly influences susceptibility. Genetic variants that exacerbate oxidative stress and endothelial injury can disrupt glomerular microvascular integrity and permeability. Together, these molecular alterations may contribute to albuminuria and progressive deterioration of renal function, as reflected by declining estimated glomerular filtration rate (eGFR). Methods: This pilot case-control study investigated the association of two genetic variants, MTHFR rs1801133 and VEGF-A rs28357093, with DN in 345 individuals from Central Brazil. Genotyping was performed using PCR-RFLP. Clinical and genetic data were analyzed using logistic regression under different inheritance models and five supervised machine learning (SML) algorithms (CART, RF, KNN, SVM, and LR). Model performance was assessed using accuracy, precision, sensitivity, specificity, ROC curve analysis, bootstrap resampling, and a sensitivity analysis excluding fasting blood glucose, serum creatinine, and eGFR. Results: The MTHFR (rs1801133) and VEGF-A (rs28357093) variants were associated with DN risk ( p = 0.05 and p = 0.02, respectively). ML analyses demonstrated high predictive performance, with RF and CART achieving the highest discriminative ability among the evaluated algorithms. KNN and LR showed high sensitivity, reaching recall values of up to 1.00. eGFR and glycated hemoglobin emerged as the most influential predictors, whereas the genetic variants provided complementary predictive information. These findings highlight the potential of ML approaches for integrating clinical and genetic data in DN risk prediction. Conclusion: ML models exhibited satisfactory predictive performance driven mainly by clinical parameters. The observed results support the potential utility of integrating genetic data into predictive workflows while highlighting the importance of larger cohorts for refining precision risk stratification in DN.
- 12 September 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 434
Open AccessGenetic Variant-based Machine Learning Prediction of Diabetic Nephropathy: A Pilot Study in Brazilian Patients
Purpose: Diabetic nephropathy (DN) is a major microvascular complication of type 2 diabetes, where genetic predisposition significantly influences susceptibility. Genetic variants that exacerbate oxidative stress and endothelial injury can disrupt glomerular microvascular integrity and permeability. Together, these molecular alterations may contribute to albuminuria and progressive deterioration of renal function, as reflected by declining estimated glomerular filtration rate (eGFR). Methods: This pilot case-control study investigated the association of two genetic variants, MTHFR rs1801133 and VEGF-A rs28357093, with DN in 345 individuals from Central Brazil. Genotyping was performed using PCR-RFLP. Clinical and genetic data were analyzed using logistic regression under different inheritance models and five supervised machine learning (SML) algorithms (CART, RF, KNN, SVM, and LR). Model performance was assessed using accuracy, precision, sensitivity, specificity, ROC curve analysis, bootstrap resampling, and a sensitivity analysis excluding fasting blood glucose, serum creatinine, and eGFR. Results: The MTHFR (rs1801133) and VEGF-A (rs28357093) variants were associated with DN risk ( p = 0.05 and p = 0.02, respectively). ML analyses demonstrated high predictive performance, with RF and CART achieving the highest discriminative ability among the evaluated algorithms. KNN and LR showed high sensitivity, reaching recall values of up to 1.00. eGFR and glycated hemoglobin emerged as the most influential predictors, whereas the genetic variants provided complementary predictive information. These findings highlight the potential of ML approaches for integrating clinical and genetic data in DN risk prediction. Conclusion: ML models exhibited satisfactory predictive performance driven mainly by clinical parameters. The observed results support the potential utility of integrating genetic data into predictive workflows while highlighting the importance of larger cohorts for refining precision risk stratification in DN.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 69, e26250464
Genetic Polymorphisms as Biomarkers of Neuroinflammation Pathway in Neurodegenerative Sclerosis: A Systematic Review and Meta-Analysis
Degenerative sclerosis, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS) are progressive diseases affecting neuronal cells, impairing muscle tone and mobility. Both pathologies have a multifactorial etiology. However, inflammation plays a significant role in neuron injury, and the genetic background can influence its susceptibility and progression. In this context, we perform a systematic review and meta-analysis aiming to identify the genetic polymorphisms that directly activate inflammatory pathways to neurodegeneration. Through research in EMBASE, SCOPUS, Web of Science, Pubmed/NCBI, and virtual health library (BVS) databases, on observational studies that addressed polymorphisms and direct neuroinflammation in ALS and/or MS presenting a statistically significant association. Studies on non-humans, non-observational reports, studies reporting indirect activation of inflammatory pathways, protective genetic association, or susceptibility only to the diseases’ progression were excluded. The methodological quality of the individual studies was assessed by Joanna Briggs Critical Appraisal Tools. Forty-two studies were included by a qualitative synthesis in this systematic review, and five polymorphisms were evaluated in the meta-analysis. For MS, the gene superfamily of interleukins was frequently reported, while VEGF-A was the major cytokine associated with ALS. In the meta-analysis, the SNPs rs2069762 in IL2, rs3212227 in IL12Β, rs1946518 in IL18, and rs3918242 in MMP9 were associated with MS susceptibility. No association was found for rs1800750 in the TNF-α gene. Despite limitations, such as the small sample size, this review highlights key genes and polymorphisms in neuroinflammatory pathways, offering insights for developing a genetic panel targeting ALS and MS susceptibility.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 69, e26250464
Open AccessGenetic Polymorphisms as Biomarkers of Neuroinflammation Pathway in Neurodegenerative Sclerosis: A Systematic Review and Meta-Analysis
Degenerative sclerosis, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS) are progressive diseases affecting neuronal cells, impairing muscle tone and mobility. Both pathologies have a multifactorial etiology. However, inflammation plays a significant role in neuron injury, and the genetic background can influence its susceptibility and progression. In this context, we perform a systematic review and meta-analysis aiming to identify the genetic polymorphisms that directly activate inflammatory pathways to neurodegeneration. Through research in EMBASE, SCOPUS, Web of Science, Pubmed/NCBI, and virtual health library (BVS) databases, on observational studies that addressed polymorphisms and direct neuroinflammation in ALS and/or MS presenting a statistically significant association. Studies on non-humans, non-observational reports, studies reporting indirect activation of inflammatory pathways, protective genetic association, or susceptibility only to the diseases’ progression were excluded. The methodological quality of the individual studies was assessed by Joanna Briggs Critical Appraisal Tools. Forty-two studies were included by a qualitative synthesis in this systematic review, and five polymorphisms were evaluated in the meta-analysis. For MS, the gene superfamily of interleukins was frequently reported, while VEGF-A was the major cytokine associated with ALS. In the meta-analysis, the SNPs rs2069762 in IL2, rs3212227 in IL12Β, rs1946518 in IL18, and rs3918242 in MMP9 were associated with MS susceptibility. No association was found for rs1800750 in the TNF-α gene. Despite limitations, such as the small sample size, this review highlights key genes and polymorphisms in neuroinflammatory pathways, offering insights for developing a genetic panel targeting ALS and MS susceptibility.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86
Genomic prediction of diabetic retinopathy via VEGF-A variants: insights from meta-analysis, machine learning and molecular docking approaches
Diabetic retinopathy (DR) is a complex ocular microvascular neurodegenerative condition resulting from chronic hyperglycemia and hypoxia. Genetic variants, particularly in the vascular endothelial growth factor A (VEGF-A) gene, play a key role in promoting pathological angiogenesis. This study conducted a systematic review and meta-analysis to identify key VEGF-A variants associated with DR development. Observational studies were retrieved from PubMed/Medline, Web of Science, Virtual Health Library, Embase, and Scopus, without time restrictions. Moreover, machine learning (ML) models were applied to enhance genetic risk prediction for DR. Additionally, molecular docking was performed to assess the impact of the −460T>C single-nucleotide variant (SNV) on the interaction between the VEGF-A promoter and the HIF1 transcription factor. Of the 20 studies included in the systematic review, 14 were eligible for meta-analysis. A significant association was found between the C allele of the rs833061 (−460T>C) variant and DR risk (OR = 1.49; 95% CI = 1.17–1.90; p = 0.0014), as well as in the dominant genotypic model (TT vs. TC + CC; OR = 1.76; 95% CI = 1.13–2.74; p = 0.0130). Although the −2549 I/D variant was not significant in the meta-analysis, ML models indicated its predictive value. Molecular docking revealed enhanced binding affinity of the −460C allele to HIF1, suggesting functional relevance. In conclusion, these findings support the potential of VEGF-A variants, particularly rs833061, as biomarkers for DR susceptibility and highlight the utility of integrating ML and molecular docking for predictive medicine.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86
Open AccessGenomic prediction of diabetic retinopathy via VEGF-A variants: insights from meta-analysis, machine learning and molecular docking approaches
Diabetic retinopathy (DR) is a complex ocular microvascular neurodegenerative condition resulting from chronic hyperglycemia and hypoxia. Genetic variants, particularly in the vascular endothelial growth factor A (VEGF-A) gene, play a key role in promoting pathological angiogenesis. This study conducted a systematic review and meta-analysis to identify key VEGF-A variants associated with DR development. Observational studies were retrieved from PubMed/Medline, Web of Science, Virtual Health Library, Embase, and Scopus, without time restrictions. Moreover, machine learning (ML) models were applied to enhance genetic risk prediction for DR. Additionally, molecular docking was performed to assess the impact of the −460T>C single-nucleotide variant (SNV) on the interaction between the VEGF-A promoter and the HIF1 transcription factor. Of the 20 studies included in the systematic review, 14 were eligible for meta-analysis. A significant association was found between the C allele of the rs833061 (−460T>C) variant and DR risk (OR = 1.49; 95% CI = 1.17–1.90; p = 0.0014), as well as in the dominant genotypic model (TT vs. TC + CC; OR = 1.76; 95% CI = 1.13–2.74; p = 0.0130). Although the −2549 I/D variant was not significant in the meta-analysis, ML models indicated its predictive value. Molecular docking revealed enhanced binding affinity of the −460C allele to HIF1, suggesting functional relevance. In conclusion, these findings support the potential of VEGF-A variants, particularly rs833061, as biomarkers for DR susceptibility and highlight the utility of integrating ML and molecular docking for predictive medicine.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e297127
Association of genetic variants with the progression of COVID-19 symptoms in diabetic patients: a systematic review and in silico protein interaction analysis
Diabetes mellitus is a global public health issue and, at the onset of the COVID-19 pandemic, was identified as a risk factor associated with high morbidity and mortality in cases of acute respiratory infection caused by the SARS-CoV-2 coronavirus. This study investigated genetic variants in diabetic patients with COVID-19 through a systematic analysis of the PubMed/NCBI, EMBASE, Web of Science, SCOPUS, and Virtual Health Library databases, with the protocol registered on the PROSPERO platform (registration number CRD42020181311). Fifteen genetic variants were associated with five specific genes in symptomatic diabetic patients with COVID-19. Inheritance models, diabetic individuals carrying the heterozygous genotype TC (VDR rs4516035) showed ~10–15-fold higher odds of symptomatic COVID-19. Protein-protein interaction (PPI) analysis showed that the proteins ACE, ACE2, IL-6, and IL-17 exhibited strong predicted interactions with each other, as well as with insulin and the TMPRSS2 protease. Limitations include small number of eligible studies, heterogeneity in populations and outcome definitions. These preliminary findings highlight the need for further studies to understand better the relationship between the identified genetic variants and the progression of COVID-19 in diabetic patients.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e297127
Open AccessAssociation of genetic variants with the progression of COVID-19 symptoms in diabetic patients: a systematic review and in silico protein interaction analysis
Diabetes mellitus is a global public health issue and, at the onset of the COVID-19 pandemic, was identified as a risk factor associated with high morbidity and mortality in cases of acute respiratory infection caused by the SARS-CoV-2 coronavirus. This study investigated genetic variants in diabetic patients with COVID-19 through a systematic analysis of the PubMed/NCBI, EMBASE, Web of Science, SCOPUS, and Virtual Health Library databases, with the protocol registered on the PROSPERO platform (registration number CRD42020181311). Fifteen genetic variants were associated with five specific genes in symptomatic diabetic patients with COVID-19. Inheritance models, diabetic individuals carrying the heterozygous genotype TC (VDR rs4516035) showed ~10–15-fold higher odds of symptomatic COVID-19. Protein-protein interaction (PPI) analysis showed that the proteins ACE, ACE2, IL-6, and IL-17 exhibited strong predicted interactions with each other, as well as with insulin and the TMPRSS2 protease. Limitations include small number of eligible studies, heterogeneity in populations and outcome definitions. These preliminary findings highlight the need for further studies to understand better the relationship between the identified genetic variants and the progression of COVID-19 in diabetic patients.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13957
Machine learning approaches and genetic determinants that influence the development of type 2 diabetes mellitus: a genetic association study in Brazilian patients
This genetic association study including 120 patients with type 2 diabetes mellitus (T2DM) and 166 non-diabetic individuals aimed to investigate the association of polymorphisms in the genes GSTM1 and GSTT1 (gene deletion), GSTP1 (rs1695), ACE (rs4646994), ACE2 (rs2285666), VEGF-A (rs28357093), and MTHFR (rs1801133) with the development of T2DM in the population of Goiás, Brazil. Additionally, the combined effects of these polymorphisms and the possible differences between sexes in susceptibility to the disease were evaluated. Finally, machine learning models were integrated to select the main risk characteristics for the T2DM diagnosis. Risk associations were found for the GSTT1-null genotype in the non-stratified sample and females, and for mutant C allele of the VEGF-A rs28357093 polymorphism in the non-stratified sample. Furthermore, an association of heterozygous (AG) and mutant (GG) GSTP1 genotypes was observed when combined with GSTT1-null. Machine learning approaches corroborated the results found. Therefore, these results suggested that GSTT1 and GSTP1 polymorphisms may contribute to T2DM susceptibility in a Brazilian sample.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13957
Open AccessMachine learning approaches and genetic determinants that influence the development of type 2 diabetes mellitus: a genetic association study in Brazilian patients
This genetic association study including 120 patients with type 2 diabetes mellitus (T2DM) and 166 non-diabetic individuals aimed to investigate the association of polymorphisms in the genes GSTM1 and GSTT1 (gene deletion), GSTP1 (rs1695), ACE (rs4646994), ACE2 (rs2285666), VEGF-A (rs28357093), and MTHFR (rs1801133) with the development of T2DM in the population of Goiás, Brazil. Additionally, the combined effects of these polymorphisms and the possible differences between sexes in susceptibility to the disease were evaluated. Finally, machine learning models were integrated to select the main risk characteristics for the T2DM diagnosis. Risk associations were found for the GSTT1-null genotype in the non-stratified sample and females, and for mutant C allele of the VEGF-A rs28357093 polymorphism in the non-stratified sample. Furthermore, an association of heterozygous (AG) and mutant (GG) GSTP1 genotypes was observed when combined with GSTT1-null. Machine learning approaches corroborated the results found. Therefore, these results suggested that GSTT1 and GSTP1 polymorphisms may contribute to T2DM susceptibility in a Brazilian sample.
- 3 November 2023
- Published by Rfb Editora
NEUROPATIA DIABÉTICA: UMA ABORDAGEM CLÍNICA E GENÉTICA
NEUROPATIA DIABÉTICA: UMA ABORDAGEM CLÍNICA E GENÉTICA
- 3 November 2023
- Published by Rfb Editora
NEUROPATIA DIABÉTICA: UMA ABORDAGEM CLÍNICA E GENÉTICA
NEUROPATIA DIABÉTICA: UMA ABORDAGEM CLÍNICA E GENÉTICA
- Open Access
- 9 November 2022
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 55 (3)
Clinical and epidemiological characteristics of patients with Amyotrophic Lateral Sclerosis (ALS) in central Brazil
Objetivo: Este estudo teve como objetivo avaliar as características clínico-epidemiológicas de pacientes com Esclerose Lateral Amiotrófica (ELA) no Estado de Goiás, Brasil. Métodos: Foi realizado um estudo transversal descritivo para avaliação de prontuários de pacientes com ELA acompanhados no Centro Médico Estadual de Reabilitação e Readaptação Dr. Henrique Santillo, Goiânia, GO, Brasil, entre 2005 e 2018. Além disso, registramos e criamos um painel fotográfico com os principais achados clínicos dos casos de ELA. Resultados: Dos 224 pacientes investigados, 51,8% eram do sexo masculino e 67,4% manifestavam a forma clássica da doença. Os sintomas iniciais foram mais frequentes em membros inferiores (37,9%) e as complicações resultaram em 45,5% de traqueostomia, 60,3% de gastrostomia e 49,1% de óbitos. A maioria dos pacientes teve sobrevida de cinco anos desde o início dos sintomas, e nenhuma associação significativa entre o uso de ventilação não-invasiva e aumento da sobrevida foi encontrada. A análise das características clínico-epidemiológicas mostrou um tempo mais prolongado entre os primeiros sintomas e o diagnóstico da doença. Conclusão: Neste estudo, o tempo entre os primeiros sintomas e o diagnóstico foi maior quando comparado à literatura, resultando em tratamentos tardios. Além disso, não houve resultado satisfatório em termos de sobrevida com o uso da ventilação não-invasiva. Portanto, estudos clínico-epidemiológicos sobre a doença no Brasil, bem como a conscientização pública e o treinamento de profissionais para o reconhecimento dos sinais clínicos de ELA, auxiliarão em intervenções precoces e mais eficazes.
- 9 November 2022
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 55 (3)
Open AccessClinical and epidemiological characteristics of patients with Amyotrophic Lateral Sclerosis (ALS) in central Brazil
Objetivo: Este estudo teve como objetivo avaliar as características clínico-epidemiológicas de pacientes com Esclerose Lateral Amiotrófica (ELA) no Estado de Goiás, Brasil. Métodos: Foi realizado um estudo transversal descritivo para avaliação de prontuários de pacientes com ELA acompanhados no Centro Médico Estadual de Reabilitação e Readaptação Dr. Henrique Santillo, Goiânia, GO, Brasil, entre 2005 e 2018. Além disso, registramos e criamos um painel fotográfico com os principais achados clínicos dos casos de ELA. Resultados: Dos 224 pacientes investigados, 51,8% eram do sexo masculino e 67,4% manifestavam a forma clássica da doença. Os sintomas iniciais foram mais frequentes em membros inferiores (37,9%) e as complicações resultaram em 45,5% de traqueostomia, 60,3% de gastrostomia e 49,1% de óbitos. A maioria dos pacientes teve sobrevida de cinco anos desde o início dos sintomas, e nenhuma associação significativa entre o uso de ventilação não-invasiva e aumento da sobrevida foi encontrada. A análise das características clínico-epidemiológicas mostrou um tempo mais prolongado entre os primeiros sintomas e o diagnóstico da doença. Conclusão: Neste estudo, o tempo entre os primeiros sintomas e o diagnóstico foi maior quando comparado à literatura, resultando em tratamentos tardios. Além disso, não houve resultado satisfatório em termos de sobrevida com o uso da ventilação não-invasiva. Portanto, estudos clínico-epidemiológicos sobre a doença no Brasil, bem como a conscientização pública e o treinamento de profissionais para o reconhecimento dos sinais clínicos de ELA, auxiliarão em intervenções precoces e mais eficazes.
- Open Access
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing multisystemic and multifactorial neurodegenerative disease that affects upper and lower motor neurons. Neuroinflammation is an important factor in neurodegeneration, the increase of immune cells in the neural tissue and degranulation of these cells causes neuronal damage and death, thus playing an important role in ALS pathophysiology. Studies have sought to use the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) as biomarkers of the inflammatory response indicative of diagnosis, stratification, progression and response to treatment of several diseases, including neurodegenerative. Thus, the aim of this study was to evaluate NLR and PLR as possible biomarkers in the neurodegenerative process. This retrospective cross-sectional study was carried out with 43 ALS patients selected at the Dr. Henrique Santillo Rehabilitation and Readaptation Center (CRER), Goiânia, Goiás – Brazil. Neutrophil, platelet, and lymphocyte counts were collected from the patient's most recent hemogram. Statistical analysis was performed using SPSS software, version 26. The correlation between NLR and PLR according to clinical condition showed a significant difference in these parameters during the initial phase of ALS development (p=0.01), revealing a marked inflammatory, with subsequent decline as the disease progresses (p=0.06). Furthermore, the results indicated a moderate positive linear relationship between the two variables (r=0.57; p<0.001), showing a joint increase in these parameters. Therefore, NLR and PLR are important indicators of inflammation and can be useful due to their simplicity, high reproducibility and low-cost for routine use.
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
Open AccessNeutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing multisystemic and multifactorial neurodegenerative disease that affects upper and lower motor neurons. Neuroinflammation is an important factor in neurodegeneration, the increase of immune cells in the neural tissue and degranulation of these cells causes neuronal damage and death, thus playing an important role in ALS pathophysiology. Studies have sought to use the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) as biomarkers of the inflammatory response indicative of diagnosis, stratification, progression and response to treatment of several diseases, including neurodegenerative. Thus, the aim of this study was to evaluate NLR and PLR as possible biomarkers in the neurodegenerative process. This retrospective cross-sectional study was carried out with 43 ALS patients selected at the Dr. Henrique Santillo Rehabilitation and Readaptation Center (CRER), Goiânia, Goiás – Brazil. Neutrophil, platelet, and lymphocyte counts were collected from the patient's most recent hemogram. Statistical analysis was performed using SPSS software, version 26. The correlation between NLR and PLR according to clinical condition showed a significant difference in these parameters during the initial phase of ALS development (p=0.01), revealing a marked inflammatory, with subsequent decline as the disease progresses (p=0.06). Furthermore, the results indicated a moderate positive linear relationship between the two variables (r=0.57; p<0.001), showing a joint increase in these parameters. Therefore, NLR and PLR are important indicators of inflammation and can be useful due to their simplicity, high reproducibility and low-cost for routine use.
- 8 October 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (2) , 1655-1659
Influence of GSTP1 rs1695 polymorphism on survival in male patients’ amyotrophic lateral sclerosis: a genetic association study in Brazilian population
Background Glutathione S-transferase Pi (GSTP1) enzyme has a major antioxidant effect on the central nervous system (CNS), where it acts against oxidative damage, an established risk factor for amyotrophic lateral sclerosis (ALS). Hence, the purpose of this study was to evaluate a possible relationship between GSTP1 rs1695 polymorphism and the survival rate of male ALS patients, which is the gender more affected by the disease. Methods and results A case-control study was performed with 56 male ALS patients and 70 healthy male individuals from Midwestern Brazil, which were age-adjusted. GSTP1 rs1695 polymorphism molecular analysis was carried out with restriction fragment length polymorphism. The relationship between ALS patients and GSTP1 rs1695 polymorphism was analyzed using cumulative survival rate as the major outcome, where differences in survival were evaluated through the log-rank test. Our results revealed that mutant genotype (G/G) did not influence the cumulative survival rate of male ALS patients regarding the age of diagnosis (p = 0.5) and time from symptom to diagnosis (p = 0.3). On the other hand, mutant carriers exhibited a significant survival of fewer than 25 months compared to A/A and A/G genotypes that survive more than 100 months (p = 7−E10) in comparison with symptom onset to outcome (p = 0.00006). Conclusions In summary, our findings revealed that mutant genotype carriers’ male patients had a reduced lifetime, which probably may be resulted from oxidative stress exposure in CNS.
- 8 October 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (2) , 1655-1659
Influence of GSTP1 rs1695 polymorphism on survival in male patients’ amyotrophic lateral sclerosis: a genetic association study in Brazilian population
Background Glutathione S-transferase Pi (GSTP1) enzyme has a major antioxidant effect on the central nervous system (CNS), where it acts against oxidative damage, an established risk factor for amyotrophic lateral sclerosis (ALS). Hence, the purpose of this study was to evaluate a possible relationship between GSTP1 rs1695 polymorphism and the survival rate of male ALS patients, which is the gender more affected by the disease. Methods and results A case-control study was performed with 56 male ALS patients and 70 healthy male individuals from Midwestern Brazil, which were age-adjusted. GSTP1 rs1695 polymorphism molecular analysis was carried out with restriction fragment length polymorphism. The relationship between ALS patients and GSTP1 rs1695 polymorphism was analyzed using cumulative survival rate as the major outcome, where differences in survival were evaluated through the log-rank test. Our results revealed that mutant genotype (G/G) did not influence the cumulative survival rate of male ALS patients regarding the age of diagnosis (p = 0.5) and time from symptom to diagnosis (p = 0.3). On the other hand, mutant carriers exhibited a significant survival of fewer than 25 months compared to A/A and A/G genotypes that survive more than 100 months (p = 7−E10) in comparison with symptom onset to outcome (p = 0.00006). Conclusions In summary, our findings revealed that mutant genotype carriers’ male patients had a reduced lifetime, which probably may be resulted from oxidative stress exposure in CNS.
- Open Access
- 19 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0247024
No association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population
Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease that affects motor neurons and promotes progressive muscle atrophy. It has a multifactorial etiology, where environmental conditions playing a remarkable role through the increase of oxidative stress. Genetic polymorphisms in cell detoxification genes, such asGlutathione S-Transferase Pi 1(GSTP1) can contribute to excessive oxidative stress, and therefore may be a risk factor to ALS. Thus, this study aimed to investigate the role of theGSTP1rs1695 polymorphism in ALS susceptibility in different genetic inheritance models and evaluate the association of the genotypes with risk factors, clinical and demographic characteristics of ALS patients from the Brazilian central population. This case-control study was conducted with 101 patients with ALS and 101 healthy controls.GSTP1rs1695 polymorphism genotyping was performed with Polymerase Chain Reaction–Restriction Fragment Length Polymorphism (PCR-RFLP). The statistical analysis was carried out using the SPSS statistical package and SNPStats software. Analysis of genetic inheritance models was performed by logistic regression, which was used to determine the Odds Ratio. The results of this first study in the Brazilian population demonstrated that there was no risk association between the development of ALS and theGSTP1rs1695 polymorphism in any genetic inheritance model (codominant, dominant, recessive, overdominant, and logarithmic); and that the polymorphic variants were not associated with the clinical and demographic characteristics of ALS patients. No association of theGSTP1rs1695 polymorphism and ALS development in the Brazilian central population was found. These findings may be justified by the multifactorial character of the disease.
- 19 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0247024
Open AccessNo association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population
Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease that affects motor neurons and promotes progressive muscle atrophy. It has a multifactorial etiology, where environmental conditions playing a remarkable role through the increase of oxidative stress. Genetic polymorphisms in cell detoxification genes, such asGlutathione S-Transferase Pi 1(GSTP1) can contribute to excessive oxidative stress, and therefore may be a risk factor to ALS. Thus, this study aimed to investigate the role of theGSTP1rs1695 polymorphism in ALS susceptibility in different genetic inheritance models and evaluate the association of the genotypes with risk factors, clinical and demographic characteristics of ALS patients from the Brazilian central population. This case-control study was conducted with 101 patients with ALS and 101 healthy controls.GSTP1rs1695 polymorphism genotyping was performed with Polymerase Chain Reaction–Restriction Fragment Length Polymorphism (PCR-RFLP). The statistical analysis was carried out using the SPSS statistical package and SNPStats software. Analysis of genetic inheritance models was performed by logistic regression, which was used to determine the Odds Ratio. The results of this first study in the Brazilian population demonstrated that there was no risk association between the development of ALS and theGSTP1rs1695 polymorphism in any genetic inheritance model (codominant, dominant, recessive, overdominant, and logarithmic); and that the polymorphic variants were not associated with the clinical and demographic characteristics of ALS patients. No association of theGSTP1rs1695 polymorphism and ALS development in the Brazilian central population was found. These findings may be justified by the multifactorial character of the disease.